Advance Research Directives in Germany: A Proposal for a Disclosure Standard

Download Edit this record How to cite View on PhilPapers
Abstract
The fourth amendment to the German Medicinal Products Act (Arzneimittelgesetz) states that nontherapeutic research in incompetent populations is permissible under the condition that potential research participants expressly declare their wish to participate in scientific research in an advance research directive. This article explores the implementation of advance research directives in Germany against the background of the international legal and ethical framework for biomedical research. In particular, it addresses a practical problem that arises from the disclosure requirement for advance research directives. We show that, if the disclosure standard for advance research directives is set at a token level, nontherapeutic research in incompetent populations becomes practically impossible. To resolve this issue, we suggest the disclosure standard be set at a type level.
Categories
(categorize this paper)
PhilPapers/Archive ID
SCHARD-5
Upload history
Archival date: 2018-05-24
View other versions
Added to PP index
2018-05-24

Total views
102 ( #46,446 of 65,538 )

Recent downloads (6 months)
10 ( #53,807 of 65,538 )

How can I increase my downloads?

Downloads since first upload
This graph includes both downloads from PhilArchive and clicks on external links on PhilPapers.